Literature DB >> 7475686

Malabsorption of vitamin E in cystic fibrosis improved after ursodeoxycholic acid.

P S Thomas, M Bellamy, D Geddes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7475686     DOI： 10.1016/s0140-6736(95)92937-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  The role of vitamins in cystic fibrosis.

Authors:  S B Carr; J McBratney
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

Review 2.  Vitamin E supplementation in people with cystic fibrosis.

Authors:  Peter O Okebukola; Sonal Kansra; Joanne Barrett
Journal:  Cochrane Database Syst Rev       Date:  2017-03-06

3.  [Endocrinologic and metabolic complications of Alagille syndrome].

Authors:  L C Hofbauer; A Mrozek-Lasota; T Jelinek; H D Schworm; D Zimmermann; A E Heufelder
Journal:  Med Klin (Munich)       Date:  1997-09-15

4.  Vitamin E supplementation in people with cystic fibrosis.

Authors:  Peter O Okebukola; Sonal Kansra; Joanne Barrett
Journal:  Cochrane Database Syst Rev       Date:  2020-09-06

Review 5.  Interventions for preventing and managing advanced liver disease in cystic fibrosis.

Authors:  Senthil K Palaniappan; Nan Nitra Than; Aung Win Thein; Soe Moe; Indra van Mourik
Journal:  Cochrane Database Syst Rev       Date:  2017-08-29

Review 6.  Interventions for preventing and managing advanced liver disease in cystic fibrosis.

Authors:  Senthil K Palaniappan; Nan Nitra Than; Aung Win Thein; Indra van Mourik
Journal:  Cochrane Database Syst Rev       Date:  2020-03-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.